Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Teijin Pharma develops bifunctional M3 antagonist and beta2-agonist compounds

April 14, 2015

Novel assay for DNA methylation predicts outcome in AML patients

April 14, 2015

oxLDL-induced apoptotic dendritic cells show efficacy as a potential therapy for atherosclerosis

April 13, 2015

Frizzled receptor antagonist attenuates adverse remodeling

April 13, 2015

Investigators report presence of CD117 in Leydig cell tumors

April 13, 2015

Researchers report CTNNB1 mutations in NMC and NMC-Fi for the first time

April 13, 2015

LXRbeta partial agonist shows potential for the treatment of atherosclerosis

April 13, 2015

DS-107 cream as a promising new treatment for atopic dermatitis

April 13, 2015

Novel sGC stimulator shows potent antihypertensive effects

April 10, 2015

New Drosophila model of nephrolithiasis presented

April 10, 2015

Popular Stories

Today's news in brief
BioWorld
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...